25 Jan Clinical guideline
Posted at 10:08h
in
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of Human Medicines containing specified substances. In addition to this guideline, SAHPRA reserves the right to request any additional information to establish the safety, quality, and efficacy of a medicine in keeping with the knowledge current at the time of evaluation. SAHPRA is committed to ensure that all registered medicines will be of the required quality, safety, and efficacy.
Download latest version
Download archived version
Download archived version
Document Number:
SAHPGL-CEM-01
Version:
3
Date Updated:
24/08/2022
File Type:
pdf
Category:
Guideline